1. Home
  2. PLUR vs EPSM Comparison

PLUR vs EPSM Comparison

Compare PLUR & EPSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pluri Inc.

PLUR

Pluri Inc.

N/A

Current Price

$1.51

Market Cap

18.5M

Sector

Health Care

ML Signal

N/A

Logo Epsium Enterprise Limited Ordinary Shares

EPSM

Epsium Enterprise Limited Ordinary Shares

N/A

Current Price

$1.60

Market Cap

18.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
PLUR
EPSM
Founded
2001
2010
Country
Israel
China
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.5M
18.9M
IPO Year
2001
2021

Fundamental Metrics

Financial Performance
Metric
PLUR
EPSM
Price
$1.51
$1.60
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$12.00
N/A
AVG Volume (30 Days)
24.9K
12.5K
Earning Date
05-08-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
10.78
N/A
EPS
N/A
N/A
Revenue
$1,336,000.00
N/A
Revenue This Year
$97.38
N/A
Revenue Next Year
$293.97
N/A
P/E Ratio
N/A
N/A
Revenue Growth
309.82
N/A
52 Week Low
$1.41
$0.83
52 Week High
$5.27
$155.00

Technical Indicators

Market Signals
Indicator
PLUR
EPSM
Relative Strength Index (RSI) 36.44 51.35
Support Level N/A $1.30
Resistance Level $1.85 $1.56
Average True Range (ATR) 0.13 0.12
MACD -0.01 -0.00
Stochastic Oscillator 8.70 41.29

Price Performance

Historical Comparison
PLUR
EPSM

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

About EPSM Epsium Enterprise Limited Ordinary Shares

Epsium Enterprise Ltd is a holding company and conducts business through its subsidiaries. It is engaged in import trading and wholesale selling of beverages in Macau. The company imports and sells a range of beverages, alcoholic beverages, and a small quantity of tea and fruit juice. The alcoholic beverages it sells include Chinese liquor, French cognac, Scottish whiskey, fine wine, Champagne, and other miscellaneous beverage alcohols.

Share on Social Networks: